ABSTRACT
To provide a better understanding of the role of placenta in vertical human immunodeficiency virus (HIV) transmission, we have studied the infection of placental trophoblast in a group of 15 mother-neonate pairs. By nested PCR amplification of the C2V3 env gene region, HIV-1 has been found to infect the placenta in five cases (33%). Phylogenetic analysis of the cloned sequences showed that all recovered maternal variants were of the B subtype. Further investigation into the ancestral relationships at the nucleotide level revealed that the trophoblast sequences evolved into a quasispecies population clearly distant from that observed in the mother. As expected, the populations transmitted to the trophoblast were also found to be more homogeneous than those in the mothers when characterized on the basis of pairwise nucleotide sequence distances. With regard to the predicted biological properties, the primary amino acid structure of the V3 loop domain was consistent, with a macrophage-tropic, non-syncytium-inducing phenotype in all patients. We also attempted to determine if any of a number of selected maternal or viral factors was associated with trophoblast infection. However, none of the followed parameters, including maternal age, disease stage, antiretroviral therapy, CCR5delta32 deletion status of the infant, and viral genotype, could be associated with viral transmission. Moreover, in one pair with proven trophoblast infection, HIV was also detected in the cord blood. Taken together, our data suggest that the productive trophoblast infection by HIV-1 in vivo is a relatively frequent event that may bear direct implications for a further transplacental propagation of the virus.
Subject(s)
HIV-1/genetics , Trophoblasts/virology , Adult , Amino Acid Sequence , Cytopathogenic Effect, Viral/genetics , Evolution, Molecular , Female , Fetal Blood/virology , Fetal Diseases/virology , HIV Envelope Protein gp120/genetics , HIV Infections/transmission , HIV Infections/virology , HIV-1/classification , HIV-1/isolation & purification , HIV-1/pathogenicity , Humans , Infant, Newborn , Molecular Sequence Data , Peptide Fragments/genetics , Phenotype , Phylogeny , Polymerase Chain Reaction , Pregnancy , Pregnancy Complications, Infectious/virology , Risk Factors , Sequence Alignment , Sequence Deletion , Sequence Homology, Amino Acid , Viremia/virology , VirulenceSubject(s)
Pan troglodytes/genetics , Receptors, CCR5/genetics , Amino Acid Sequence , Animals , CD4 Antigens/genetics , HIV Infections , HIV-1/pathogenicity , Molecular Sequence Data , Phylogeny , Polymerase Chain Reaction , Sequence Alignment , Sequence Analysis, DNA , Sequence Homology, Amino Acid , Species SpecificitySubject(s)
DNA-Binding Proteins/genetics , HIV Long Terminal Repeat/genetics , HIV-1/genetics , Nuclear Proteins/genetics , Africa, Southern , Amino Acid Sequence , Base Sequence , CCAAT-Enhancer-Binding Proteins , Genes, Viral/genetics , Genetic Variation/genetics , Genetic Variation/immunology , Genotype , HIV Seropositivity/genetics , HIV-1/classification , HIV-1/isolation & purification , Humans , Male , Molecular Sequence Data , Phenotype , Sequence Analysis, DNA , Sequence Homology, Nucleic Acid , Transcription Factors/chemistry , Transcription Factors/geneticsSubject(s)
HIV Envelope Protein gp120/genetics , HIV-1/genetics , Peptide Fragments/genetics , Amino Acid Sequence , Consensus Sequence , HIV Envelope Protein gp120/chemistry , HIV-1/classification , Humans , Kenya , Molecular Sequence Data , Peptide Fragments/chemistry , Phylogeny , Polymorphism, Genetic , Sequence Homology, Amino AcidABSTRACT
We have analysed the capacity of the trophoblast-derived malignant cell lines BeWo, JAR and JEG-3, and primary cultures of highly purified trophoblast cells to support the basal and Tat-mediated trans-activation-enhanced transcriptional activity of two distinct human immunodeficiency virus type 1 (HIV-1) isolates. Kinetic studies based on expression of long terminal repeat (LTR)-chloramphenicol acetyltransferase (CAT) constructs revealed that LTRs of both the prototype strain 3B and the highly cytopathic Zairean variant NDK were activated significantly in all target cells. Overall, the strongest activation was observed in primary trophoblasts. A novel modification of quantitative PCR was used to normalize LTR expression for transfection efficiency, enabling the calculation of specific expression rates in terms of muU CAT enzyme per fmol of transfected DNA. Using the latter criterion we determined that LTRs of both viruses were activated in decreasing order from trophoblasts to JAR, JEG-3 and BeWo cells; furthermore, the expression of HIV-1 3B LTR always significantly surpassed that of HIV-1 NDK. The effects of trans-activation on either of the LTRs, when assayed in cotransfection assays with various amounts of HIV-1 NDK-Tat expression vector, increased in a dose-dependent fashion and were comparable in a particular neoplastic cell line. Furthermore, the cell-specific LTR activity patterns did not correspond to the abundance of transcription factors binding specifically to the viral NF kappa B and SP1 motifs. Unlike SP1-binding proteins which were relatively abundant, substantially smaller amounts of proteins with NF kappa B specificity were found in all cells. Despite this apparent deficit in NF kappa B activity, trophoblasts supported a high basal activity of both LTRs. These data indicate that an insufficiency of basal or Tat-trans-activated LTR activity cannot account for the low level of HIV-1 replication in this important cell type.